4.6 Article

BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells

Journal

CELL CYCLE
Volume 13, Issue 18, Pages 2869-2878

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/15384101.2014.946834

Keywords

BRG1; chromatin remodeling; HDACs; telomerase; telomeres; beta-catenin

Categories

Funding

  1. National Natural Science Foundation of China [20921062, 30570960]
  2. National Basic Research Program of China [2014CB964703]
  3. Guangdong Innovative Research Team Program [201001Y0104687244]
  4. Shenzhen Science & Technology Program [ZDSY20120616222747467]

Ask authors/readers for more resources

Telomerase is often upregulated during initiation and/or progression of human tumors, suggesting that repression of telomerase might inhibit cancer growth or progression. Here, we report that BRG1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is a general suppressor of hTERT transcription in human cancer cells. While overexpression of BRG1 inhibits hTERT transcription, depletion of BRG1 stimulates transcription of hTERT, leading to higher telomerase activity and longer telomeres. Chromatin-immunoprecipitation assays revealed that BRG1 binds to the transcription start site (TSS) of the hTERT promoter and forms a ternary complex with histone deacetylase 2 (HDAC2). BRG1 remodels chromatin structure to facilitate the action of HDAC2, leading to deacetylation of H3K9ac and H4ac at the TSS and suppression of hTERT transcription. On the other hand, -catenin binds to the TSS and stimulates hTERT transcription. Thus, BRG1/HDAC2 and -catenin constitute a manipulative apparatus at the TSS to play opposite but complementary roles in regulating hTERT expression. These results uncover a yin-yang mechanism in modulating hTERT transcription and provide explanation for limited transcription of hTERT in human cancer cells. BRG1/HDAC2 may have a potential as an anti-cancer therapeutic and/or for reactivating cellular proliferative capacity in the context of in vitro tissue engineering.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available